SouthState’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$626 Hold
14
– – ﹤0.01% 1226
2026
Q2
$1.11K Hold
14
– – ﹤0.01% 1090
2026
Q1
$1.05K Hold
14
– – ﹤0.01% 1036
2025
Q4
$1.11K Sell
14
-19
-58% -$1.43K ﹤0.01% 1097
2025
Q3
$2.16K Sell
33
-18
-35% -$879 ﹤0.01% 919
2025
Q2
$2.02K Sell
51
-68
-57% -$2.22K ﹤0.01% 1092
2025
Q1
$3.59K Buy
+119
New +$3.9K ﹤0.01% 1053

Other funds holding IONS

SouthState's IONS Position: Q3 2026 in Review

SouthState held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 14 shares worth $626. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

SouthState first reported a position in IONS in Q1 2025 and has held it in 7 quarters since. The position peaked at $3.59K in Q1 2025. 351 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • SouthState held 14 shares of Ionis Pharmaceuticals worth $626 as of Q3 2026.
  • SouthState left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1226 holding.
  • SouthState first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
  • SouthState's Ionis Pharmaceuticals position peaked at $3.59K in Q1 2025.
  • 351 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.